Sepulveda Waldo, Corral Edgardo, Aiello Horacio, Otaño Lucas, Paredes Ricardo, Escobar Maria F, Heredia Fernando, Quiroz Victor
Fetal Medicine Center, Clinica Las Condes, Santiago, Chile.
Fetal Diagn Ther. 2004 Sep-Oct;19(5):448-52. doi: 10.1159/000078998.
To report a multicenter experience with intrafetal alcohol chemosclerosis in the treatment of pregnancies complicated with the twin reversed arterial perfusion sequence.
Percutaneous injection of 1- 2 ml of absolute alcohol into the intra-abdominal segment of the single umbilical artery was performed in 8 acardiac twins. Cases were collected from 5 centers following a standardized protocol. The procedure was performed under continuous ultrasound control, using color Doppler ultrasound to identify the main arterial vessel entering the abdomen of the acardiac twin and passing a 20-gauge spinal needle into the targeted vessel. Intraoperative and short-term complications were noted. Information on pregnancy outcome was obtained by reviewing the medical records or contacting the referring obstetrician.
At the time of the procedure, the acardiac twin was severely hydropic and the size exceeded 70% of the size of the pump twin in all cases. In addition, there were associated complications in all the pump twins including polyhydramnios in 8 cases (100%), cardiac insufficiency in 5 (63%), and fetal growth restriction in 1 (13%). The procedure was performed at a mean gestational age of 24.7 weeks (range 20-32), and it was technically successful in all cases. However, it was complicated with thrombosis of the umbilical vessels of the pump twin in 1 case, and transient bradycardia in 2 others. These 3 pump twins died in utero as a result of the procedure. The other 5 procedures were technically and clinically successful, resulting in an overall survival rate of 63%. In 4 pregnancies, the pump twin was delivered after 35 weeks and had no neonatal complications.
Intrafetal alcohol chemosclerosis is a simple procedure that can be performed in any fetal medicine center around the world to stop the vascular supply to acardiac twins. However, the main concern with this technique is intravascular transfer of the ablative material to the circulation of the pump twin. The use of this technique should therefore be restricted to those pregnancies with poor prognostic factors and in countries where more sophisticated methods for the treatment of this condition are not available.
报告多中心使用胎儿酒精化学硬化疗法治疗合并双胎反向动脉灌注序列妊娠的经验。
对8例无心畸形双胎经皮向单脐动脉的腹内段注射1 - 2毫升无水酒精。按照标准化方案从5个中心收集病例。该操作在持续超声监测下进行,使用彩色多普勒超声识别进入无心畸形双胎腹部的主要动脉血管,并将一根20号脊椎穿刺针插入目标血管。记录术中及短期并发症。通过查阅病历或联系转诊的产科医生获取妊娠结局信息。
在操作时,所有病例中无心畸形双胎均严重水肿,其大小超过供血双胎大小的70%。此外,所有供血双胎均伴有相关并发症,包括羊水过多8例(100%)、心脏功能不全5例(63%)、胎儿生长受限1例(13%)。操作时的平均孕周为24.7周(范围20 - 32周),所有病例技术上均成功。然而,1例供血双胎出现脐血管血栓形成,另外2例出现短暂性心动过缓。这3例供血双胎因该操作在子宫内死亡。其他5例操作在技术和临床方面均成功,总体存活率为63%。在4例妊娠中,供血双胎在35周后分娩,无新生儿并发症。
胎儿酒精化学硬化疗法是一种简单的操作,可在世界任何胎儿医学中心进行,以阻断无心畸形双胎的血管供应。然而,该技术的主要问题是消融材料血管内转移至供血双胎的循环。因此,该技术的使用应限于那些预后因素较差的妊娠以及在没有更复杂治疗方法的国家。